Analyst Reco. Agenus Inc.

Equities

AGEN

US00847G8042

Market Closed - Nasdaq Other stock markets 01:30:00 01/05/2024 am IST			5-day change	1st Jan Change
12.12 ^USD	-5.02%		+87.62%	-26.80%

12/04	Sector Update: Health Care Stocks Slipping Late Afternoon	MT
12/04	Sector Update: Health Care	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating	18/03	MT
B. Riley Lowers Agenus' Price Target to $6 From $8, Maintains Buy Rating	09/11	MT
Baird Initiates Agenus at Outperform With $8 Price Target	06/23/06	MT
HC Wainwright Assumes Agenus at Buy With $8 Price Target	28/23/28	MT
EF Hutton Starts Agenus With Buy Rating, Sets Price Target at $8.30	22/22/22	MT
EF Hutton Initiates Agenus With Buy Rating, Price Target is $8.3	08/22/08	MT
SMBC Nikko Starts Agenus at Outperform With $5 Price Target	28/22/28	MT
B. Riley Lowers Agenus' Price Target to $8 from $11, Keeps Buy Rating	03/22/03	MT
HC Wainwright Adjusts Agenus' Price Target to $14 from $12, Reiterates Buy Rating	02/22/02	MT
HC Wainwright Starts Agenus at Buy With $12 Price Target	16/21/16	MT
Agenus : Says Cervical Cancer Combination Therapy Shows 'High' Response Rates in Phase 2 Trial	17/21/17	MT
AGENUS : B. Riley Raises Agenus' PT to $12 from $11, Says Continued Regulatory Progress to Drive Stock Price Performance; Keeps Buy Rating	07/21/07	MT
AGENUS : B. Riley Raises Agenus' PT to $11 from $8, Notes Value Accretive Catalysts; Keeps Buy Rating	29/21/29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer